![Daniel W. Kollin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel W. Kollin
Corporate Officer/Principal at
BioMed Capital Group Ltd.
Profile
Daniel W.
Kollin was re-appointed a Director of American Bio Medica Corp.
in January 2004 and was a Director from February 2003 to September 2003.
He has been Managing Director of BioMed Capital Group Ltd. since 1990 and is a Director of IsoTis, Inc. Mr. Kollin received an MBA from The Wharton School of The University of Pennsylvania.
Daniel W. Kollin active positions
| Companies | Position | Start |
|---|---|---|
BioMed Capital Group Ltd. | Corporate Officer/Principal | 1989-12-31 |
Former positions of Daniel W. Kollin
| Companies | Position | End |
|---|---|---|
| AMERICAN BIO MEDICA CORPORATION | Director/Board Member | 2009-08-02 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
American Bio Medica Corp.
 American Bio Medica Corp. Medical SpecialtiesHealth Technology Manufactures, develops and sells immunoassay diagnostic test kits | Health Technology |
BioMed Capital Group Ltd. |
- Stock Market
- Insiders
- Daniel W. Kollin
